This statistic displays the number of substance abuse treatment facilities in the United States by state as of 2020. During this period, there were 611 substance abuse treatment facilities located in North Carolina.

In 2023, there were 17,561 substance abuse treatment facilities in the country, an increase from the year before. This statistic displays the total number of substance abuse treatment facilities in the United States from 2003 to 2022.

This dataset shows characteristics of the Inpatient Rehabilitation Facilities (IRFs) that are shown on Inpatient Rehabilitation Facility Compare. It includes a list of IRFs with information such as address, phone number, state, city and county data with the information about Centers for Medicare & Medicaid Services (CMS) Regions where each of the IRFs are located. This dataset also contains data regarding different measure codes and their corresponding scores for majority of the IRFs.

The Estonian Drug Treatment Database is a state register which is kept on the people who have started drug treatment. The Drug Treatment Database started its work on January 1, 2008.

Collection and processing of data on these people is necessary for getting an overview on occurrence of mental and behavioural disorders related to drug use, as well as for organising of relevant health services and planning of drug abuse preventive actions. Health care institutions holding a psychiatry authorization in Estonia present data to the database if they are turned to by a patient who is diagnosed with a mental and behavioural disorder due to drug use.

On the basis of the database's data, an annual overview is compiled, giving information about drug addicts who have turned to drug treatment in the previous calendar year, about the health service provided, the patients' socio-economic background, drug use and the related risk behaviour.

The data on the Drug Treatment Database are also submitted to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and United Nations Office on Drugs and Crime (UNODC).

This statistic displays the total number of clients in U.S. substance abuse treatment facilities from 2007 to 2020. In 2020, there were 1,090,357 clients in local, county, or community government run substance abuse treatment facilities.

This is an alphabetical list by county of all non-medical alcoholism and drug abuse recovery or treatment facilities licensed and/or certified by the Department of Health Care Services (DHCS). Within DHCS, the Substance Use Disorder Compliance (SUDC) Division Licensing and Certification Branch (LCB) is responsible for assuring that quality services are provided to all program participants in a safe and healthful environment through the licensure, certification, regulation, and oversight of a statewide system of alcohol and other drug recovery and treatment facilities and programs and counselors.

The Treatment Episode Data Set -- Admissions (TEDS-A) is a national census data system of annual admissions to substance abuse treatment facilities. TEDS-A provides annual data on the number and characteristics of persons admitted to public and private substance abuse treatment programs that receive public funding. The unit of analysis is a treatment admission. TEDS consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA. A sister data system, called the Treatment Episode Data Set -- Discharges (TEDS-D), collects data on discharges from substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006. TEDS variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)". Variables in the MDS include: information on service setting, number of prior treatments, primary source of referral, sex, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008). Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances. Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.This study has 1 Data Set.

This dataset includes the list of inpatient rehabilitation facilities with data on the number of times people with Medicare who had certain medical conditions were treated in the last year.

This study examined the relationship between legal pressure and drug treatment retention by assessing perceptions of legal pressure held by two groups of legally-mandated treatment clients: (1) participants of the Drug Treatment Alternative to Prison (DTAP) program operated by the Kings County (Brooklyn) District Attorney in New York City, and (2) a matched group of probationers, parolees, Treatment Alternatives to Street Crime (TASC) participants, and other court-mandated offenders attending the same community-based treatment programs used by DTAP. The Brooklyn DTAP was selected for study because of the program's uniquely coercive program components, including the threat of a mandatory prison term for noncompliance. The goals of this project were (1) to test whether DTAP participants would show significantly higher retention rates when compared to a matched sample of other legally-mandated treatment clients, and (2) to assess the role of perceived legal pressure in predicting retention for both of these groups. Data were collected from program participants through interviews conducted at admission to treatment and follow-up interviews conducted about eight weeks later. Intake interviews were conducted, on average, one week after the client's admission to treatment. The one-to-one interviews, which lasted up to two hours, were administered by trained researchers in a private location at the treatment site. The intake interview battery included a mixture of standardized measures and those developed by the Vera Institute of Justice. Data in Part 1 were collected with the Addiction Severity Index and include age, sex, race, religion, and education. Additional variables cover medical problems, employment history, detailed substance abuse and treatment history, number of times arrested for various crimes, history of incarceration, family's substance abuse and criminal histories, relationships with family and friends, psychological problems such as depression, anxiety, and suicide, current living arrangements, and sources of income. Part 2, Supplemental Background and Retention Data, contains treatment entry date, number of days in treatment, age at treatment entry, termination date, treatment condition, arrest date, detention at arrest, date released on probation/parole, violation of probation/parole arrest date and location, problem drug, prior drug treatment, as well as age, gender, race, education, and marital status. Part 3, Division of Criminal Justice Services Data, includes data on the number of arrests before and after program entry, and number of total misdemeanor and felony arrests, convictions, and sentences. Part 4, Chemical Use, Abuse, and Dependence Data, contains information on type of substance abuse, intoxication or withdrawal at work, school, or home, effects of abuse on social, occupational, or recreational activities, and effects of abuse on relationships, health, emotions, and employment. Parts 5 and 6 contain psychiatric data gathered from the Symptom Checklist-90-Revised and Beck's Depression Inventory, respectively. Part 7 variables from the Circumstances, Motivation, Readiness, and Suitability scale include family's attitude toward treatment, subject's need for treatment, subject's desire to change life, and legal consequences if subject did not participate in treatment. Part 8, Stages of Change Readiness and Treatment Eagerness scale, contains data on how the subject viewed the drug problem, desire to change, and history of dealing with substance abuse. Part 9, Motivational/Program Supplement Data, includes variables on the subject's need for treatment, attitudes toward treatment sessions, the family's reaction to treatment, and a likelihood of completion rating. Part 10, Perceived Legal Coercion Data, gathered information on who referred the subject to the treatment program, who was keeping track of attendance, whether someone explained the rules of participation in the program and the consequences if the subject failed the program, whether the rules and consequences were put in writing, who monitored program participants, the likelihood of using drugs while in treatment, the likelihood of leaving the program before completion, whether the subject understood the legal consequences of failing the program, the type and frequency of reports and contacts with the criminal justice system, and the subject's reaction to various penalties for not completing the program. Part 11 contains data from the Community Oriented Programs Environment Scale (COPES). Part 12, Treatment Services Review Data, includes data on the number of times the subject received medical attention, days in school, days employed, days intoxicated, days in substance abuse treatment, days tested for drugs, number of contacts with the criminal justice system, days treated for psychological problems, and time spent at recreational activities. Additional variables include the number of individual and group treatment sessions spent discussing medical problems, education and employment, substance abuse, legal problems, and psychological and emotional problems.

In financial year 2021, over 128 thousand people in India received drug de-addiction treatment. It was significantly higher compared to the previous financial year. However, this was still a decrease from the number of people under de-addiction treatment in financial year 2016.

The Treatment Episode Data Set -- Discharges (TEDS-D) is a national census data system of annual discharges from substance abuse treatment facilities. TEDS-D provides annual data on the number and characteristics of persons discharged from public and private substance abuse treatment programs that receive public funding. Data collected both at admission and at discharge is included. The unit of analysis is a treatment discharge. TEDS-D consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA. A sister data system, called the Treatment Episode Data Set -- Admissions (TEDS-A), collects data on admissions to substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006. TEDS-D variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)". Variables unique to TEDS-D, and not part of TEDS-A, are the length of stay, reason for leaving treatment, and service setting at time of discharge. TEDS-D also provides many of the same variables that exist in TEDS-A. This includes information on service setting, number of prior treatments, primary source of referral, sex, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008) . Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances. Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.This study has 1 Data Set.

This statistic displays the number of substance abuse treatment clients in the United States by state, as of 2020. As of that year, there were 35,874 substance abuse treatment clients located in North Carolina.

The California Drug and Alcohol Treatment Assessment (CALDATA) was designed to study the costs, benefits, and effectiveness of the state's alcohol and drug treatment infrastructure (recovery services) and specifically to assess (1) the effects of treatment on participant behavior, (2) the costs of treatment, and (3) the economic value of treatment to society. Data were collected on participants (clients) across four types of treatment programs, or modalities: residential, residential "social model," nonmethadone outpatient, and outpatient methadone (detoxification and maintenance). Data were collected in two phases. In Phase 1, treatment records were abstracted for clients who received treatment or were discharged between October 1, 1991, and September 30, 1992. In Phase 2, these clients were located and recruited for a follow-up interview. The CALDATA design and procedures included elements from several national treatment outcome studies including the Drug Services Research Survey, Services Research Outcomes Study, National Treatment Improvement Evaluation Study, and Drug Abuse Treatment Outcome Study. The record abstract was designed to collect identifying and locating information for interview reference during the personal interviewing phase. The abstract also collected demographic, drug, or alcohol use, and treatment and service information. The follow-up questionnaire covered time periods before, during, and after treatment and focused on topics such as ethnic and educational background, drug and alcohol use, mental and physical health, HIV and AIDS status, drug testing, illegal activities and criminal status, living arrangements and family issues, employment and income, and treatment for drug, alcohol, and mental health problems. Drugs included alcohol, barbiturates, benzodiazepines, cocaine powder, crack, downers, hallucinogens, heroin, illegal methadone, inhalants, LSD, marijuana/hashish/THC, methamphetamines and other stimulants, narcotics, over-the-counter drugs, PCP, ritalin or preludin, and sedatives/hypnotics. CALDATA was originally known as the California Outcomes Study (COS).This study has 1 Data Set.

The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator http://findtreatment.samhsa.gov. Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, pharmacotherapies, testing, transitional, ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed/prescribed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.This study has 1 Data Set.

Financial overview and grant giving statistics of Addiction Recovery Center

The Uniform Facility Data Set (UFDS), formerly the National Drug and Alcohol Treatment Unit Survey or NDATUS, was designed to measure the scope and use of drug abuse treatment services in the United States. The survey collects information from each privately- and publicly-funded facility in the country that provides substance abuse treatment as well as from state-identified facilities that provide other substance abuse services. Data are collected on a number of topics including facility operation, services provided (assessment, therapy, testing, health, continuing care, programs for special groups, transitional services, community outreach, ancillary), type of treatment, facility capacity, numbers of clients, and various client characteristics. The main objective of the UFDS is to produce data that can be used to assess the nature and extent of substance abuse treatment services, to assist in the forecast of treatment resource requirements, to analyze treatment service trends, to conduct national, regional, and state-level comparative analyses of treatment services and utilization, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its on-line equivalent, the Substance Abuse Treatment Facility Locator http://findtreatment.samhsa.gov. Additionally, the UFDS provides information that can be used to design sampling frames for other surveys of substance abuse treatment facilities.This study has 1 Data Set.

This dataset contains data from a cluster randomised trial, with hospitals randomly allocated to receive either an education-only intervention or a multifaceted intervention to improve rehabilitation assessment practices. The outcome of interest was documentation of rehabilitation needs in the medical records of patients with stroke by a health professional providing ward-based care in the acute hospital. Data were also collected about documentation of rehabilitation needs by rehabilitation service representatives, whether patients accessed rehabilitation when they were discharged from the acute hospital ward or hospital, whether patients were admitted to an acute stroke unit, and discharge destination.
Demographic data of patients were collected including sex, age, pre-stroke living situation (home alone, home with others, residential care), pre-stroke mobility (independent, not independent) stroke severity (National Institute of Health Stroke Scale, NIHSS), stroke type (Oxfordshire Stroke Classification) and whether the person was born in Australia.

The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator http://findtreatment.samhsa.gov.
Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, testing, transitional, and ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.This study has 1 Data Set.

SSA used ARRA funding for disability and retirement workloads, constructing and partially equipping our National Support Center and for administering the Economic Recovery Payments.